2.525
전일 마감가:
$2.64
열려 있는:
$2.61
하루 거래량:
359.01K
Relative Volume:
0.08
시가총액:
$45.07M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-2.68%
1개월 성능:
+124.78%
6개월 성능:
-23.95%
1년 성능:
-33.68%
Mural Oncology Plc Stock (MURA) Company Profile
명칭
Mural Oncology Plc
전화
353 1 905 8020
주소
10 EARLSFORT TERRACE, DUBLIN 2
MURA을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
MURA
Mural Oncology Plc
|
2.53 | 45.07M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
500.01 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
603.22 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ARGX
Argen X Se Adr
|
655.86 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
273.48 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
254.64 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-03-25 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2025-03-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
2024-06-28 | 개시 | Rodman & Renshaw | Buy |
2024-04-04 | 개시 | Morgan Stanley | Overweight |
Mural Oncology Plc 주식(MURA)의 최신 뉴스
Layoff Tracker: Pliant Cuts 45% of Staff To Extend Cash Runway - BioSpace
Geode Capital Management LLC Sells 9,027 Shares of Mural Oncology plc (NASDAQ:MURA) - Defense World
Goldman Sachs adjusts positions in Mural Oncology shares By Investing.com - Investing.com Nigeria
BlackRock discloses stake in Mural Oncology By Investing.com - Investing.com South Africa
BlackRock discloses stake in Mural Oncology - Investing.com Australia
Form 8.3Mural Oncology plc - Business Wire
Goldman Sachs adjusts positions in Mural Oncology shares - Investing.com Australia
Goldman Sachs discloses stake in Mural Oncology - Investing.com
Renaissance Technologies LLC Boosts Stock Holdings in Mural Oncology plc (NASDAQ:MURA) - Defense World
Ovarian Cancer Market: Epidemiology, Therapies, Companies, - openpr.com
BlackRock discloses stake in Mural Oncology plc - Investing.com
BlackRock discloses stake in Mural Oncology plc By Investing.com - Investing.com India
Goldman Sachs adjusts stake in Mural Oncology - Investing.com
Mural Oncology plc Opening Position Disclosure Under Irish Takeover Rules - Nasdaq
FORM 8.1(a) & (b)Mural Oncology plc - The Manila Times
Mural Oncology Takeover Speculation Heats Up as CEO Stakes Revealed: 900K+ Total Shares - Stock Titan
Tang Capital reports stake in Mural Oncology - Investing.com
March sees multiple phase III successes, boosting Corcept and Mineralys - BioWorld MedTech
LMR Partners reports 2.997% stake in Mural Oncology By Investing.com - Investing.com South Africa
BlackRock discloses stake in Mural Oncology amid takeover rules By Investing.com - Investing.com South Africa
Tang Capital reports 1.2% stake in Mural Oncology By Investing.com - Investing.com South Africa
Tang Capital reports 1.2% stake in Mural Oncology - Investing.com Australia
BlackRock discloses stake in Mural Oncology amid takeover rules - Investing.com Australia
LMR Partners reports 2.997% stake in Mural Oncology - Investing.com Australia
Tang Capital discloses stake in Mural Oncology By Investing.com - Investing.com India
Tang Capital discloses stake in Mural Oncology - Investing.com
Solas Capital discloses dealings in Mural Oncology shares By Investing.com - Investing.com India
Solas Capital discloses dealings in Mural Oncology shares - Investing.com
BlackRock reports stake in Mural Oncology By Investing.com - Investing.com India
BlackRock reports stake in Mural Oncology - Investing.com Australia
Quarterly Metrics: Quick and Current Ratios for Mural Oncology plc (MURA) - DWinneX
Geode Capital reports 1.02% stake in Mural Oncology By Investing.com - Investing.com South Africa
Largest borrow rate increases among liquid names - TipRanks
Geode Capital reports 1.02% stake in Mural Oncology - Investing.com
Holdings of Mural Oncology plc (MURA) are aligned with the stars - Sete News
Mural Oncology Plc (MURA) 재무 분석
Mural Oncology Plc (MURA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Mural Oncology Plc 주식 (MURA) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Keson-Brookes Maiken | See Remarks |
Mar 05 '25 |
Sale |
3.45 |
1,469 |
5,068 |
73,564 |
Keson-Brookes Maiken | See Remarks |
Mar 04 '25 |
Sale |
3.36 |
1,262 |
4,240 |
75,033 |
Loew Caroline | Chief Executive Officer |
Mar 04 '25 |
Sale |
3.36 |
4,313 |
14,492 |
305,590 |
자본화:
|
볼륨(24시간):